News
For the study, researchers from Imperial College London, University of Leicester, UCL and University of Leeds analysed ...
Mereo BioPharma Group plc's ORBIT study for setrusumab in osteogenesis imperfecta moves to final analysis by 2025. Click for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback